Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 9—September 2021

Geographically Targeted Interventions versus Mass Drug Administration to Control Taenia solium Cysticercosis, Peru

Seth E. O’NealComments to Author , Ian W. Pray, Percy Vilchez, Ricardo Gamboa, Claudio Muro, Luz Maria Moyano, Viterbo Ayvar, Cesar M. Gavidia, Robert H. Gilman, Armando E. Gonzalez, Hector H. Garcia, and for the Cysticercosis Working Group in Peru
Author affiliations: Oregon Health & Science University–Portland State University School of Public Health, Portland, Oregon, USA (S.E. O’Neal, I.W. Pray); Universidad Peruana Cayetano Heredia, Lima, Peru (S.E. O’Neal, P. Vilchez, R. Gamboa, C. Muro, L.M. Moyano, H.H. Garcia); Universidad Nacional Mayor de San Marcos, Lima (V. Ayvar, C.M. Gavidia, A.E. Gonzalez); Johns Hopkins University, Baltimore, Maryland, USA. (R.H. Gilman)

Main Article

Table 2

Summary of participation in mass treatment intervention in a study on control of Taenia solium cysticercosis, Peru*

Characteristics Study month
0 6 12 18 24
No. eligible households
No. eligible participants 2,994 2,973 3,021 2,956 2,998 14,942
Not treated, no. (%) 709 (23.7) 743 (25.0) 819 (27.1) 755 (25.5) 730 (24.4) 3,756 (25.1)
Took >1 dose of NSM, no. (%) 2,285 (76.3) 2,230 (75.0) 2,202 (72.9) 2,201 (74.5) 2,268 (75.7) 11,186 (74.9)

*Distinct households and participants might be counted more than once in the totals column. NSM, niclosamide.

Main Article

Page created: June 28, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.